For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
USP Rivaroxaban Assay and Organic Impurities - System Suitability Solution run on Waters® AQUITY® H-Class
28026
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Pharmaceutical
Pharmaceutical
Therapeutic / Clinical

USP Rivaroxaban Assay and Organic Impurities - System Suitability Solution run on Waters® AQUITY® H-Class

Analytes
1Related Compound B
2Related Compound D
3Related Compound G
4Rivaroxaban
5Related Compound J
Details
LC Conditions (App ID: 28026)
Column:
Brand Name:
Luna Omega
Part No:
Phase Name:
C18
System:
Waters ACQUITY UPLC H-Class Waters ACQUITY UPLC H-Class
Sample Note:
Solution B: 5.3mM sodium hexane sulfonate, 3.77mM phosphoric acid in water Diluent: Acetonitrile and solution B (40:60) System suitability solution: 0.5 mg/mL of USP Rivaroxaban RS and 0.5 µg/mL each of USP Rivaroxaban Related Compound B RS, USP Rivaroxaban Related Compound D RS, USP Rivaroxaban Related Compound G RS, and USP Rivaroxaban Related Compound J RS in Diluent​ peak no. 1 analyte name: rivaroxaban related compound G RT (min): 14.878 conc.: 0.5ug/mL peak no. 2 analyte name: rivaroxaban RT (min): 16.438 conc.: 0.5 mg/mL
Similar Applications
search
No Data